Solésence Publishes Restated 2024 Annual Report

• Solésence restated its 2024 annual results, cutting net income to $1.1 million from $4.24 million over inventory-costing errors.
• Inventory fell $4.65 million to $15.62 million; cost of revenue rose $3.14 million to $39.3 million.
• The 2023 net loss widened to $4.94 million from $4.39 million; operating cash flows were unchanged in both years.
• Management identified material weaknesses in inventory costing and financial reporting oversight, concluding internal controls were ineffective as of December 31, 2024.
• Executive compensation clawbacks totaled $252,785, with $158,447 outstanding as of October 9, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solesence Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001999371-26-025091), on November 10, 2026, and is solely responsible for the information contained therein.